Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RALTITREXED for Malignant peritoneal neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where RALTITREXED was used for Malignant peritoneal neoplasm.

Most Reported Side Effects for RALTITREXED

Side Effect Reports % Deaths Hosp.
Diarrhoea 82 19.2% 22 27
Myelosuppression 77 18.0% 0 48
Anaemia 49 11.5% 4 14
Neutropenia 48 11.2% 4 20
Vomiting 46 10.8% 9 17
Nausea 45 10.5% 9 13
Disease progression 40 9.4% 12 11
Fatigue 38 8.9% 1 13
Asthenia 33 7.7% 4 12
Hepatic function abnormal 26 6.1% 1 8
Off label use 25 5.8% 1 6
Bone marrow failure 23 5.4% 0 8
Decreased appetite 21 4.9% 0 5
Thrombocytopenia 21 4.9% 1 2
Rash 20 4.7% 0 9

Other Indications for RALTITREXED

Colon cancer (63) Colorectal cancer metastatic (47) Adenocarcinoma of colon (35) Rectal cancer (31) Colorectal cancer (28) Rectal adenocarcinoma (18) Metastases to liver (17) Hepatic cancer (14) Adenocarcinoma gastric (13) Chemotherapy (13)

Other Drugs Used for Malignant peritoneal neoplasm

NIRAPARIB (1,632) CARBOPLATIN (361) BEVACIZUMAB (340) RUCAPARIB CAMSYLATE (332) PACLITAXEL (274) OLAPARIB (190) DOXORUBICIN (97) ATEZOLIZUMAB (67) DOCETAXEL (49) OXALIPLATIN (46)

Related Pages

RALTITREXED Full Profile All Malignant peritoneal neoplasm Drugs RALTITREXED Demographics RALTITREXED Timeline